84 related articles for article (PubMed ID: 26260705)
1. Randomized, dose-finding trial of ghrelin treatment for chronic respiratory failure.
Miki K; Maekura R; Nakazato M; Matsumoto N; Kitada S; Miki M; Yoshimura K; Mori M; Kangawa K
Clin Respir J; 2017 Jul; 11(4):496-505. PubMed ID: 26260705
[TBL] [Abstract][Full Text] [Related]
2. Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment.
Miki K; Maekura R; Nagaya N; Kitada S; Miki M; Yoshimura K; Tateishi Y; Motone M; Hiraga T; Mori M; Kangawa K
BMC Pulm Med; 2013 Jun; 13():37. PubMed ID: 23758800
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin administration for chronic respiratory failure: a randomized dose-comparison trial.
Matsumoto N; Miki K; Tsubouchi H; Sakamoto A; Arimura Y; Yanagi S; Iiboshi H; Yoshida M; Souma R; Ishimoto H; Yamamoto Y; Yatera K; Yoshikawa M; Sagara H; Iwanaga T; Mukae H; Maekura R; Kimura H; Nakazato M; Kangawa K
Lung; 2015 Apr; 193(2):239-47. PubMed ID: 25634352
[TBL] [Abstract][Full Text] [Related]
4. Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.
Miki K; Maekura R; Nagaya N; Miki M; Kitada S; Yoshimura K; Mori M; Kangawa K
J Physiol Sci; 2015 May; 65(3):277-84. PubMed ID: 25724656
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial.
Miki K; Maekura R; Nagaya N; Nakazato M; Kimura H; Murakami S; Ohnishi S; Hiraga T; Miki M; Kitada S; Yoshimura K; Tateishi Y; Arimura Y; Matsumoto N; Yoshikawa M; Yamahara K; Kangawa K
PLoS One; 2012; 7(5):e35708. PubMed ID: 22563468
[TBL] [Abstract][Full Text] [Related]
6. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD.
Eves ND; Sandmeyer LC; Wong EY; Jones LW; MacDonald GF; Ford GT; Petersen SR; Bibeau MD; Jones RL
Chest; 2009 Mar; 135(3):609-618. PubMed ID: 19017883
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanisms.
Miki K; Maekura R; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Kagawa H; Oshitani Y; Satomi A; Nishida K; Sawa N; Inoue K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1061-1070. PubMed ID: 28435239
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of high-intensity and anaerobic threshold programs in rehabilitation for patients with moderate to severe chronic obstructive pulmonary disease].
Wen H; Gao Y; An JY
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):571-6. PubMed ID: 19080398
[TBL] [Abstract][Full Text] [Related]
9. Effects of Oxygen Supply During Training on Subjects With COPD Who Are Normoxemic at Rest and During Exercise: A Blinded Randomized Controlled Trial.
Spielmanns M; Fuchs-Bergsma C; Winkler A; Fox G; Krüger S; Baum K
Respir Care; 2015 Apr; 60(4):540-8. PubMed ID: 25516993
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Rehabilitation in COPD: Effect of 2 Aerobic Exercise Intensities on Subject-Centered Outcomes--A Randomized Controlled Trial.
Santos C; Rodrigues F; Santos J; Morais L; Bárbara C
Respir Care; 2015 Nov; 60(11):1603-9. PubMed ID: 26221044
[TBL] [Abstract][Full Text] [Related]
11. One-Legged Cycle Training for Chronic Obstructive Pulmonary Disease. A Pragmatic Study of Implementation to Pulmonary Rehabilitation.
Evans RA; Dolmage TE; Mangovski-Alzamora S; Romano J; O'Brien L; Brooks D; Goldstein RS
Ann Am Thorac Soc; 2015 Oct; 12(10):1490-7. PubMed ID: 26291542
[TBL] [Abstract][Full Text] [Related]
12. Oral
Hirai DM; Jones JH; Zelt JT; da Silva ML; Bentley RF; Edgett BA; Gurd BJ; Tschakovsky ME; O'Donnell DE; Neder JA
J Appl Physiol (1985); 2017 May; 122(5):1351-1361. PubMed ID: 28255088
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of telephone-mentoring with home-based walking preceding rehabilitation in COPD.
Cameron-Tucker HL; Wood-Baker R; Joseph L; Walters JA; Schüz N; Walters EH
Int J Chron Obstruct Pulmon Dis; 2016; 11():1991-2000. PubMed ID: 27601892
[TBL] [Abstract][Full Text] [Related]
14. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
Singh D; Papi A; Corradi M; Pavlišová I; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Vestbo J
Lancet; 2016 Sep; 388(10048):963-73. PubMed ID: 27598678
[TBL] [Abstract][Full Text] [Related]
15. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
[TBL] [Abstract][Full Text] [Related]
16. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease.
Deacon SJ; Vincent EE; Greenhaff PL; Fox J; Steiner MC; Singh SJ; Morgan MD
Am J Respir Crit Care Med; 2008 Aug; 178(3):233-9. PubMed ID: 18420964
[TBL] [Abstract][Full Text] [Related]
18. Effects of unsupported upper extremity exercise training in patients with COPD: a randomized clinical trial.
Costi S; Crisafulli E; Degli Antoni F; Beneventi C; Fabbri LM; Clini EM
Chest; 2009 Aug; 136(2):387-395. PubMed ID: 19567487
[TBL] [Abstract][Full Text] [Related]
19. Benefits of pulmonary rehabilitation in patients with COPD and normal exercise capacity.
Lan CC; Chu WH; Yang MC; Lee CH; Wu YK; Wu CP
Respir Care; 2013 Sep; 58(9):1482-8. PubMed ID: 23287013
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study.
Carone M; Patessio A; Ambrosino N; Baiardi P; Balbi B; Balzano G; Cuomo V; Donner CF; Fracchia C; Nava S; Neri M; Pozzi E; Vitacca M; Spanevello A
Respir Med; 2007 Dec; 101(12):2447-53. PubMed ID: 17728121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
